Ex-EMA chief ran consultancy firm whilst still in office
December 19, 2011Sales and Marketing EMA, Lonngren, NDA
The former head of the European Medicines Agency Thomas Lonngren set up his own consultancy business to advise pharma whilst …
Key product launches of 2011
December 19, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2011, Actos, Benlysta, Brilique, Eliquis, Eylea, Incivek, Jevtana, Multaq, Victrelis, Xalkori, Yervoy, Zytiga, avastin, gilenya, key products
Avastin 2011 saw a handful of high profile drugs suffer because of new safety and efficacy concerns. Chief among these …
Vertex chief to step down; names Jeffrey Leiden as new leader
December 19, 2011Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Abbott, Vertex
Vertex has named a new chief executive to succeed Matthew Emmens, who will retire early next year. He will be …
Priorclave Success at London Vet show
December 19, 2011Manufacturing and Production
During the recent London Vet Show the autoclave featured on the Southwest Medical stand R30 certainly proved a popular visitor …
University Teaching Labs Buy into Priorclaves for Better Performance
December 19, 2011Manufacturing and Production
York University is shortly taking delivery of a number of priorclaves for use in the Biology Department’s Teaching Laboratories and …
Sanofi sheds dermatology unit for $423 million
December 19, 2011Manufacturing and Production, Sales and Marketing Canada, Dermik, Sanofi
Sanofi has completed the sale of its Canadian-based dermatology business Dermik for $422.5 million. The unit has been sold to …
EMA panel gives positive opinion for Roche’s Zelboraf
December 16, 2011Sales and Marketing EMA, Roche, Zelboraf
The EMA’s advisory committee is recommending the approval of Roche’s skin cancer drug Zelboraf. The European regulator’s Committee for Medicinal …
Best Moments of 2011
December 16, 2011Business Services, Medical Communications NHS, NHS reforms
Health Secretary Andrew Lansley was on the end of a verbal battering by GP and journalist Dr Phil Hammond on …
Amgen’s chief executive and chairman Kevin Sharer to retire
December 16, 2011Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Amgen
Kevin Sharer, Amgen’s chairman and chief executive, has announced his retirement next year, leading the way for Robert Bradway to …
Chandler Chicco acquires German comms firms
December 16, 2011Medical Communications Chandler Chicco, Haas & Health Partner Public Relations, SanCom Creative Communication Solutions.
Chandler Chicco Companies is to acquire German healthcare communication firms, Haas & Health Partner Public Relations and SanCom Creative Communication …
Merck and Roche begin combination hep C trial
December 16, 2011Research and Development, Sales and Marketing Copegus, Merck, Pegasys, Roche, Victrelis
Merck and Roche have started clinical trials to investigate combinations of their hepatitis C drugs. The first trial is designed …
BMS in cholesterol alliance with China’s Simcere
December 16, 2011Sales and Marketing BMS, CETP inhibitor, Simcere, cardiovascular, emerging markets
Bristol-Myers Squibb is to co-develop a new compound to treat cardiovascular disease with Chinese firm Simcere Pharmaceutical Group. The companies, …
Lisa Anson appointed as president of AstraZeneca’s UK marketing
December 15, 2011Business Services, Manufacturing and Production, Medical Communications, Sales and Marketing AstraZeneca, Lisa Anson
AstraZeneca has appointed Lisa Anson as its new president for the firm’s UK marketing company, effective 1 January 2012. Anson …
Optimising your brand – one bite at a time
December 15, 2011Business Services, Medical Communications, Sales and Marketing Alex Blyth, MSI, brand, marketing
Brand managers invest a huge amount of time every year preparing brand plans – but often without really knowing what …
Novartis opens cell-based flu vaccine plant in US
December 15, 2011Manufacturing and Production Novartis, celll-based, vaccines
Novartis has officially started production at a first-of-its kind cell-based manufacturing facility for influenza vaccines in North Carolina, US. The …
Lilly planning new Irish biopharma plant
December 15, 2011Manufacturing and Production lilly, manufactuing
Eli Lilly has filed a planning application to build a new 23,000 sq. m. biologics facility at its manufacturing site …
Boehringer expands manufacturing in China
December 15, 2011Manufacturing and Production Boehringer, China, manufacturing
Boehringer Ingelheim plans to invest €50 million in its manufacturing plant in Shanghai as part of a drive to increase …
Debts will force hospitals to close
December 15, 2011Sales and Marketing NHS, hospitals, king's fund
Around twenty hospitals in England may have to merge or close because of major financial problems, according to a committee …
Roche makes changes in its corporate executive committee
December 15, 2011Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Roche
Roche has made two new appointments in its corporate executive committee. Sophie Kornowski-Bonnet, currently general manager of Roche in France, …
Frazier defends R&D investment and attacks price pressure
December 14, 2011Research and Development, Sales and Marketing Merck, R&D productivity, prices
Merck & Co chief executive Kenneth Frazier has expressed concern that European governments increasingly want to pay unrealistically low prices …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
